Skip to main content
NCBI home page
Nature Portfolio logoLink to Nature Portfolio
. 2021 Jun 9;35(7):2142–2143. doi: 10.1038/s41375-021-01306-1

Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis

Hagop M Kantarjian 1,✉,#, Timothy P Hughes 2,3,#, Richard A Larson 4, Dong-Wook Kim 5, Surapol Issaragrisil 6, Philipp le Coutre 7, Gabriel Etienne 8, Carla Boquimpani 9,10, Ricardo Pasquini 11, Richard E Clark 12, Viviane Dubruille 13, Ian W Flinn 14, Slawomira Kyrcz-Krzemien 15, Ewa Medras 16, Maria Zanichelli 17, Israel Bendit 18, Silvia Cacciatore 19, Ksenia Titorenko 20, Paola Aimone 19, Giuseppe Saglio 21, Andreas Hochhaus 22
PMCID: PMC8414785  PMID: 34108614

Correction to: Leukemia 35:20-LEU-1554R

10.1038/s41375-020-01111-2 published online 07 January 2021

We found an error within Fig. 2B of the manuscript, and unfortunately this was not caught prior to submission and publication. Attached please find the corrected Fig. 2B.graphic file with name 41375_2021_1306_Fig1_HTML.jpg

Articles from Leukemia are provided here courtesy of Nature Publishing Group

RESOURCES